{"id":26915,"date":"2020-07-07T11:12:39","date_gmt":"2020-07-07T11:12:39","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=26915"},"modified":"2020-07-07T11:12:39","modified_gmt":"2020-07-07T11:12:39","slug":"dopamine-34-dihydroxyphenylethylamine","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/","title":{"rendered":"Dopamine (3,4-dihydroxyphenylethylamine)"},"content":{"rendered":"

A catecholamine neurotransmitter found in the brain. Neuropathology involving dopaminergic systems in the brain is associated with some forms of psychosis and movement disorders. Dopamine is the primary neurotransmitter involved in the reward pathways in the brain. Consequently, drugs that increase dopamine signaling (i.e., dopamine agonists) may produce euphoric effects.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

A catecholamine neurotransmitter found in the brain. Neuropathology involving dopaminergic systems in the brain is associated with some forms of psychosis and movement disorders. Dopamine is the primary neurotransmitter involved in the reward pathways in the brain. Consequently, drugs that increase dopamine signaling (i.e., dopamine agonists) may produce euphoric effects.  <\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-26915","post","type-post","status-publish","format-standard","hentry","category-d"],"yoast_head":"\nDopamine (3,4-dihydroxyphenylethylamine) - Definition of Dopamine (3,4-dihydroxyphenylethylamine)<\/title>\n<meta name=\"description\" content=\"A catecholamine neurotransmitter found in the brain. Neuropathology involving dopaminergic systems in the brain is associated with some forms of psychosis and movement disorders. Dopamine is the primary neurotransmitter involved in the reward pathways in the brain. Consequently, drugs that increase dopamine signaling (i.e., dopamine agonists) may produce euphoric effects.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dopamine (3,4-dihydroxyphenylethylamine) - Definition of Dopamine (3,4-dihydroxyphenylethylamine)\" \/>\n<meta property=\"og:description\" content=\"A catecholamine neurotransmitter found in the brain. Neuropathology involving dopaminergic systems in the brain is associated with some forms of psychosis and movement disorders. Dopamine is the primary neurotransmitter involved in the reward pathways in the brain. Consequently, drugs that increase dopamine signaling (i.e., dopamine agonists) may produce euphoric effects.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-07T11:12:39+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/\",\"name\":\"Dopamine (3,4-dihydroxyphenylethylamine) - Definition of Dopamine (3,4-dihydroxyphenylethylamine)\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-07T11:12:39+00:00\",\"dateModified\":\"2020-07-07T11:12:39+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A catecholamine neurotransmitter found in the brain. Neuropathology involving dopaminergic systems in the brain is associated with some forms of psychosis and movement disorders. Dopamine is the primary neurotransmitter involved in the reward pathways in the brain. Consequently, drugs that increase dopamine signaling (i.e., dopamine agonists) may produce euphoric effects.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dopamine (3,4-dihydroxyphenylethylamine)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dopamine (3,4-dihydroxyphenylethylamine) - Definition of Dopamine (3,4-dihydroxyphenylethylamine)","description":"A catecholamine neurotransmitter found in the brain. Neuropathology involving dopaminergic systems in the brain is associated with some forms of psychosis and movement disorders. Dopamine is the primary neurotransmitter involved in the reward pathways in the brain. Consequently, drugs that increase dopamine signaling (i.e., dopamine agonists) may produce euphoric effects.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/","og_locale":"en_US","og_type":"article","og_title":"Dopamine (3,4-dihydroxyphenylethylamine) - Definition of Dopamine (3,4-dihydroxyphenylethylamine)","og_description":"A catecholamine neurotransmitter found in the brain. Neuropathology involving dopaminergic systems in the brain is associated with some forms of psychosis and movement disorders. Dopamine is the primary neurotransmitter involved in the reward pathways in the brain. Consequently, drugs that increase dopamine signaling (i.e., dopamine agonists) may produce euphoric effects.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/","og_site_name":"Glossary","article_published_time":"2020-07-07T11:12:39+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/","name":"Dopamine (3,4-dihydroxyphenylethylamine) - Definition of Dopamine (3,4-dihydroxyphenylethylamine)","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-07T11:12:39+00:00","dateModified":"2020-07-07T11:12:39+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A catecholamine neurotransmitter found in the brain. Neuropathology involving dopaminergic systems in the brain is associated with some forms of psychosis and movement disorders. Dopamine is the primary neurotransmitter involved in the reward pathways in the brain. Consequently, drugs that increase dopamine signaling (i.e., dopamine agonists) may produce euphoric effects.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopamine-34-dihydroxyphenylethylamine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Dopamine (3,4-dihydroxyphenylethylamine)"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/26915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=26915"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/26915\/revisions"}],"predecessor-version":[{"id":26916,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/26915\/revisions\/26916"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=26915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=26915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=26915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}